… patients with coronary heart disease. … cardiovascular events in patients with COVID-19. It
is uncertain whether NLR could be a biomarker to predicting cardiovascular events in patients …

… In summary, a total of 44 coronary heart disease patients scheduled for elective, non-cardiac
surgery was screened for eligibility. Of those, 40 patients were successfully enrolled into the …

… marker whose role in cardiovascular disease has been studied extensively in the past few
years. The neutrophil lymphocyte ratio has been shown to predict cardiac arrhythmias as well …

… Neutrophil to lymphocyte ratio (NLR) might be associated with the mortality or major adverse
cardiac events (MACEs) in acute coronary syndrome (ACS) patients. We performed a meta-…

… neutrophil-to-lymphocyte ratio (NLR) is an emerging biomarker useful for predicting the risk
and prognosis of cardiovascular diseases … for patients with cardiovascular (CV) disease [11]. …

… neutrophil-to-lymphocyte ratio and long-term cardiac … coronary artery disease. Atherosclerosis.
2017;265:35-40. … An elevated neutrophil-lymphocyte ratio independently predicts mortality …

… The neutrophil-to-lymphocyte (N/L) ratio has been associated with poor outcomes in patients
with cardiovascular diseases, but it has not been studied in elderly patients with chronic …

… This systematic review aimed to measure the association between neutrophil lymphocyte
ratio (NLR) and cardiovascular disease (CVD) risk. Methods. Relevant studies were identified …

… neutrophil–lymphocyte ratio (NLR), defined as the ratio of absolute counts of neutrophils
and lymphocytes… and prognosis of atherosclerotic cardiovascular disease (CVD), and in …

… However, NLR has been shown to independently predict the risk of ESRD in patients
with advanced CKD, and to a small extent, in patients with early CKD [Citation11]. …